1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Flurbiprofen Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Flurbiprofen Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Injection
  • 1.4.3 Patch
  • 1.4.4 Tablet
• 1.5 Market by Application
  • 1.5.1 Global Flurbiprofen Market Share by Application: 2020 VS 2026
  • 1.5.2 Nonsteroidal Anti-Inflammatory Drugs
  • 1.5.3 Topical Administration for Joint And Muscle Pain
  • 1.5.4 Soft Tissue Disease
  • 1.5.5 Dysmenorrhea
  • 1.5.6 Post-Operative Pain
  • 1.5.7 Toothache
  • 1.5.8 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends by Regions

• 2.1 Flurbiprofen Market Perspective (2015-2026)
• 2.2 Flurbiprofen Growth Trends by Regions
  • 2.2.1 Flurbiprofen Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Flurbiprofen Historic Market Share by Regions (2015-2020)
  • 2.2.3 Flurbiprofen Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Flurbiprofen Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Flurbiprofen Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Flurbiprofen Players by Market Size
  • 3.1.1 Global Top Flurbiprofen Players by Revenue (2015-2020)
  • 3.1.2 Global Flurbiprofen Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Flurbiprofen Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Flurbiprofen Market Concentration Ratio
  • 3.2.1 Global Flurbiprofen Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Flurbiprofen Revenue in 2019
• 3.3 Flurbiprofen Key Players Head office and Area Served
• 3.4 Key Players Flurbiprofen Product Solution and Service
• 3.5 Date of Enter into Flurbiprofen Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Flurbiprofen Historic Market Size by Type (2015-2020)
• 4.2 Global Flurbiprofen Forecasted Market Size by Type (2021-2026)

5 Flurbiprofen Breakdown Data by Application (2015-2026)

• 5.1 Global Flurbiprofen Market Size by Application (2015-2020)
• 5.2 Global Flurbiprofen Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Flurbiprofen Market Size (2015-2020)
• 6.2 Flurbiprofen Key Players in North America (2019-2020)
• 6.3 North America Flurbiprofen Market Size by Type (2015-2020)
• 6.4 North America Flurbiprofen Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Flurbiprofen Market Size (2015-2020)
• 7.2 Flurbiprofen Key Players in Europe (2019-2020)
• 7.3 Europe Flurbiprofen Market Size by Type (2015-2020)
• 7.4 Europe Flurbiprofen Market Size by Application (2015-2020)

8 China

• 8.1 China Flurbiprofen Market Size (2015-2020)
• 8.2 Flurbiprofen Key Players in China (2019-2020)
• 8.3 China Flurbiprofen Market Size by Type (2015-2020)
• 8.4 China Flurbiprofen Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Flurbiprofen Market Size (2015-2020)
• 9.2 Flurbiprofen Key Players in Japan (2019-2020)
• 9.3 Japan Flurbiprofen Market Size by Type (2015-2020)
• 9.4 Japan Flurbiprofen Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Flurbiprofen Market Size (2015-2020)
• 10.2 Flurbiprofen Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Flurbiprofen Market Size by Type (2015-2020)
• 10.4 Southeast Asia Flurbiprofen Market Size by Application (2015-2020)

11 India

• 11.1 India Flurbiprofen Market Size (2015-2020)
• 11.2 Flurbiprofen Key Players in India (2019-2020)
• 11.3 India Flurbiprofen Market Size by Type (2015-2020)
• 11.4 India Flurbiprofen Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Flurbiprofen Market Size (2015-2020)
• 12.2 Flurbiprofen Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Flurbiprofen Market Size by Type (2015-2020)
• 12.4 Central & South America Flurbiprofen Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Teva
  • 13.1.1 Teva Company Details
  • 13.1.2 Teva Business Overview and Its Total Revenue
  • 13.1.3 Teva Flurbiprofen Introduction
  • 13.1.4 Teva Revenue in Flurbiprofen Business (2015-2020))
  • 13.1.5 Teva Recent Development
• 13.2 Mylan Pharmaceuticals
  • 13.2.1 Mylan Pharmaceuticals Company Details
  • 13.2.2 Mylan Pharmaceuticals Business Overview and Its Total Revenue
  • 13.2.3 Mylan Pharmaceuticals Flurbiprofen Introduction
  • 13.2.4 Mylan Pharmaceuticals Revenue in Flurbiprofen Business (2015-2020)
  • 13.2.5 Mylan Pharmaceuticals Recent Development
• 13.3 Tokuhon
  • 13.3.1 Tokuhon Company Details
  • 13.3.2 Tokuhon Business Overview and Its Total Revenue
  • 13.3.3 Tokuhon Flurbiprofen Introduction
  • 13.3.4 Tokuhon Revenue in Flurbiprofen Business (2015-2020)
  • 13.3.5 Tokuhon Recent Development
• 13.4 Recordati
  • 13.4.1 Recordati Company Details
  • 13.4.2 Recordati Business Overview and Its Total Revenue
  • 13.4.3 Recordati Flurbiprofen Introduction
  • 13.4.4 Recordati Revenue in Flurbiprofen Business (2015-2020)
  • 13.4.5 Recordati Recent Development
• 13.5 Mikasa Seiyaku
  • 13.5.1 Mikasa Seiyaku Company Details
  • 13.5.2 Mikasa Seiyaku Business Overview and Its Total Revenue
  • 13.5.3 Mikasa Seiyaku Flurbiprofen Introduction
  • 13.5.4 Mikasa Seiyaku Revenue in Flurbiprofen Business (2015-2020)
  • 13.5.5 Mikasa Seiyaku Recent Development
• 13.6 Bausch Health
  • 13.6.1 Bausch Health Company Details
  • 13.6.2 Bausch Health Business Overview and Its Total Revenue
  • 13.6.3 Bausch Health Flurbiprofen Introduction
  • 13.6.4 Bausch Health Revenue in Flurbiprofen Business (2015-2020)
  • 13.6.5 Bausch Health Recent Development
• 13.7 Pfizer
  • 13.7.1 Pfizer Company Details
  • 13.7.2 Pfizer Business Overview and Its Total Revenue
  • 13.7.3 Pfizer Flurbiprofen Introduction
  • 13.7.4 Pfizer Revenue in Flurbiprofen Business (2015-2020)
  • 13.7.5 Pfizer Recent Development
• 13.8 AbbVie
  • 13.8.1 AbbVie Company Details
  • 13.8.2 AbbVie Business Overview and Its Total Revenue
  • 13.8.3 AbbVie Flurbiprofen Introduction
  • 13.8.4 AbbVie Revenue in Flurbiprofen Business (2015-2020)
  • 13.8.5 AbbVie Recent Development
• 13.9 Abbott
  • 13.9.1 Abbott Company Details
  • 13.9.2 Abbott Business Overview and Its Total Revenue
  • 13.9.3 Abbott Flurbiprofen Introduction
  • 13.9.4 Abbott Revenue in Flurbiprofen Business (2015-2020)
  • 13.9.5 Abbott Recent Development
• 13.10 Allergan
  • 13.10.1 Allergan Company Details
  • 13.10.2 Allergan Business Overview and Its Total Revenue
  • 13.10.3 Allergan Flurbiprofen Introduction
  • 13.10.4 Allergan Revenue in Flurbiprofen Business (2015-2020)
  • 13.10.5 Allergan Recent Development
• 13.11 Pharma-Logic
  • 10.11.1 Pharma-Logic Company Details
  • 10.11.2 Pharma-Logic Business Overview and Its Total Revenue
  • 10.11.3 Pharma-Logic Flurbiprofen Introduction
  • 10.11.4 Pharma-Logic Revenue in Flurbiprofen Business (2015-2020)
  • 10.11.5 Pharma-Logic Recent Development
• 13.12 Kaken Pharma
  • 10.12.1 Kaken Pharma Company Details
  • 10.12.2 Kaken Pharma Business Overview and Its Total Revenue
  • 10.12.3 Kaken Pharma Flurbiprofen Introduction
  • 10.12.4 Kaken Pharma Revenue in Flurbiprofen Business (2015-2020)
  • 10.12.5 Kaken Pharma Recent Development
• 13.13 Mitsubishi Tanab
  • 10.13.1 Mitsubishi Tanab Company Details
  • 10.13.2 Mitsubishi Tanab Business Overview and Its Total Revenue
  • 10.13.3 Mitsubishi Tanab Flurbiprofen Introduction
  • 10.13.4 Mitsubishi Tanab Revenue in Flurbiprofen Business (2015-2020)
  • 10.13.5 Mitsubishi Tanab Recent Development
• 13.14 Sun Pharma
  • 10.14.1 Sun Pharma Company Details
  • 10.14.2 Sun Pharma Business Overview and Its Total Revenue
  • 10.14.3 Sun Pharma Flurbiprofen Introduction
  • 10.14.4 Sun Pharma Revenue in Flurbiprofen Business (2015-2020)
  • 10.14.5 Sun Pharma Recent Development
• 13.15 Aa Pharma
  • 10.15.1 Aa Pharma Company Details
  • 10.15.2 Aa Pharma Business Overview and Its Total Revenue
  • 10.15.3 Aa Pharma Flurbiprofen Introduction
  • 10.15.4 Aa Pharma Revenue in Flurbiprofen Business (2015-2020)
  • 10.15.5 Aa Pharma Recent Development
• 13.16 Pro Doc Limitee
  • 10.16.1 Pro Doc Limitee Company Details
  • 10.16.2 Pro Doc Limitee Business Overview and Its Total Revenue
  • 10.16.3 Pro Doc Limitee Flurbiprofen Introduction
  • 10.16.4 Pro Doc Limitee Revenue in Flurbiprofen Business (2015-2020)
  • 10.16.5 Pro Doc Limitee Recent Development
• 13.17 PD-Rx Pharmaceuticals
  • 10.17.1 PD-Rx Pharmaceuticals Company Details
  • 10.17.2 PD-Rx Pharmaceuticals Business Overview and Its Total Revenue
  • 10.17.3 PD-Rx Pharmaceuticals Flurbiprofen Introduction
  • 10.17.4 PD-Rx Pharmaceuticals Revenue in Flurbiprofen Business (2015-2020)
  • 10.17.5 PD-Rx Pharmaceuticals Recent Development
• 13.18 Beijing Taide Pharmaceutical
  • 10.18.1 Beijing Taide Pharmaceutical Company Details
  • 10.18.2 Beijing Taide Pharmaceutical Business Overview and Its Total Revenue
  • 10.18.3 Beijing Taide Pharmaceutical Flurbiprofen Introduction
  • 10.18.4 Beijing Taide Pharmaceutical Revenue in Flurbiprofen Business (2015-2020)
  • 10.18.5 Beijing Taide Pharmaceutical Recent Development
• 13.19 Wuhan Daan Pharmaceutical
  • 10.19.1 Wuhan Daan Pharmaceutical Company Details
  • 10.19.2 Wuhan Daan Pharmaceutical Business Overview and Its Total Revenue
  • 10.19.3 Wuhan Daan Pharmaceutical Flurbiprofen Introduction
  • 10.19.4 Wuhan Daan Pharmaceutical Revenue in Flurbiprofen Business (2015-2020)
  • 10.19.5 Wuhan Daan Pharmaceutical Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer

This report focuses on the global Flurbiprofen status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Flurbiprofen development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Teva
Mylan Pharmaceuticals
Tokuhon
Recordati
Mikasa Seiyaku
Bausch Health
Pfizer
AbbVie
Abbott
Allergan
Pharma-Logic
Kaken Pharma
Mitsubishi Tanab
Sun Pharma
Aa Pharma
Pro Doc Limitee
PD-Rx Pharmaceuticals
Beijing Taide Pharmaceutical
Wuhan Daan Pharmaceutical

Market segment by Type, the product can be split into
Injection
Patch
Tablet
Market segment by Application, split into
Nonsteroidal Anti-Inflammatory Drugs
Topical Administration for Joint And Muscle Pain
Soft Tissue Disease
Dysmenorrhea
Post-Operative Pain
Toothache
Other

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Flurbiprofen status, future forecast, growth opportunity, key market and key players.
To present the Flurbiprofen development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Flurbiprofen are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.